Analysis of Potential Conflicts of Interest among Otolaryngologic Patient Advocacy Organizations in 2016

Abstract

Patient advocacy organizations (PAOs) are nonprofits dedicated to benefiting patients and their families through activities such as education/counseling and research funding. Although medical drug/device companies may serve as important partners, industry donations may bias the efforts of PAOs. We conducted a retrospective cross-sectional analysis of the Kaiser Health News nonprofit database to identify and characterize otolaryngologic PAOs (n = 32) active in 2016. Among these PAOs, half (n = 16, 50.0%) focused on otologic diseases, and mean total annual revenue was $3.1 million. Among the 15 PAOs (46.9%) with publicly available donor lists, 10 (66.7%) received donations from industry. Few PAOs publicly reported the total amount donated by industry (n = 3, 9.4%) or published policies for mitigating potential financial conflicts of interest with donors (n = 3, 9.4%). Requiring drug and device companies to publicly report donations to PAOs may help patients, providers, and policy makers to better understand advocacy by these influential stakeholders.

Keywords

patient advocacy organization conflict of interest industry otolaryngology

Get full access to this article

View all access options for this article.

References

Rose

Highland

Karafa

Joffe

. Patient advocacy organizations, industry funding, and conflicts of interest. JAMA Intern Med. 2017;177:344-350.

McCoy

Carniol

Chockley

Urwin

Emanuel

Schmidt

. Conflicts of interest for patient-advocacy organizations. N Engl J Med. 2017;376:880-885.

Janssen Biotech. About Cancer.com. https://www.cancer.com/about. Published 2019. Accessed May 15, 2019.

McCoy

. Industry support of patient advocacy organizations: the case for an extension of the Sunshine Act provisions of the Affordable Care Act. Am J Public Health. 2018;108:1026-1030.

McCaskill

. Fueling an Epidemic: Exposing the Financial Ties between Opioid Manufacturers and Third Party Advocacy Groups. Washington, DC: Committee on Homeland Security and Governmental Affairs; 2018.

Singer

Mostaghimi

. Prevalence and disclosure of potential conflicts of interest in dermatology patient advocacy organizations. JAMA Dermatol. 2019;155:460-464.

Abola

Prasad

. Industry funding of cancer patient advocacy organizations. Mayo Clin Proc. 2016;91:1668-1670.

Kopp

Lupkin

Knight

. Pre$cription for power: methodology and sources. https://khn-data-projects.herokuapp.com/patient-advocacy/methodology. Published 2018. Accessed January 10, 2019.

Pre$cription for power. Kaiser Health news. https://khn.org/patient-advocacy/#. Published 2018. Accessed January 10, 2019.

10.

American Academy of Otolaryngology—Head and Neck Surgery Foundation. Advocacy. https://www.entnet.org/content/legislative-political-affairs. Published 2019. Accessed May 5, 2019.

11.

Rose

. Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness. J Law Med Ethics. 2013;41:680-687.

12.

Rathi

Samuel

Mehra

. Industry ties in otolaryngology: initial insights from the Physician Payment Sunshine Act. Otolaryng Head Neck Surg. 2015;152:993-999.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB